Evaluation of Immunochromatographic Tests for Campylobacter Detection in Stools
NCT02274922 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 308
Last updated 2017-08-28
Summary
For a long time, culture was the only way to detect Campylobacter. It appears that rapid immunochromatographic tests (ICT) have detected more positive cases compared to culture, ELISA and molecular tests. The aim of our study is to evaluate the specificity of the ICT which are really interesting tools to use since they allow a diagnosis in about 15 min, in comparison to different methods of detection even serology.
Conditions
Sponsors & Collaborators
-
University Hospital, Bordeaux
lead OTHER
Principal Investigators
-
Perez Paul, MD · Unité de Soutien Méthodologique à la Recherche clinique et épidémiologique du CHU de Bordeaux
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- France
Study Locations
More Related Trials
-
Immune Response to C.Difficile Infection
NCT02797288 ·Status: UNKNOWN
-
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody
NCT00304408 ·Status: COMPLETED
-
C Difficile Near-patient Diagnostics
NCT03857464 ·Status: COMPLETED ·Phase: NA
-
FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff
NCT02254811 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections
NCT03223415 ·Status: COMPLETED ·Phase: NA
-
Study of Clostridioides Difficile in Infants
NCT06788769 ·Status: RECRUITING
-
Small Bowel Transit Time in Clostridium Difficile Colitis
NCT01309750 ·Status: TERMINATED
-
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
NCT06071312 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis
NCT02439372 ·Status: COMPLETED
-
Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics
NCT03117582 ·Status: COMPLETED
-
Fecal Calprotectin Level in Patients With Nosocomial Diarrhea
NCT04491799 ·Status: COMPLETED
-
Host Immune Response to Clostridium Difficile Infection (ICD)
NCT02440438 ·Status: COMPLETED ·Phase: NA
-
Ursodeoxycholic Acid in C. Difficile Infection
NCT05526807 ·Status: TERMINATED ·Phase: NA
-
Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection
NCT01048112 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)
NCT01716533 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms
NCT06524791 ·Status: NOT_YET_RECRUITING
-
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
NCT03353506 ·Status: COMPLETED ·Phase: PHASE2
-
The Association of Gut Microbiota With COVID 19 Infection in Children
NCT05303155 ·Status: UNKNOWN
-
Study on Clostridium Difficile Infection in Chinese Patients With Inflammatory Bowel Disease
NCT04179201 ·Status: UNKNOWN
-
Natural History of Clostridioides Difficile Infection
NCT04801862 ·Status: RECRUITING
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Freeze-dried, Capsulized FMT for RCDI
NCT02399618 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Tolerability of FMT Capsules in Healthy Volunteers
NCT05352269 ·Status: UNKNOWN ·Phase: PHASE1
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED